NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
38 hedge funds and large institutions have $4.34M invested in Navidea Biopharmaceuticals Inc. in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
38
Holding in Top 10
–
Calls
$397K
Puts
$372K
Top Buyers
| 1 | +$898K | |
| 2 | +$189K | |
| 3 | +$111K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.2K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$90.3K |
Top Sellers
| 1 | -$413K | |
| 2 | -$413K | |
| 3 | -$258K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$185K |
| 5 |
VF
Virtu Financial
New York
|
-$69K |